Medical Communications

Showing 15 posts of 6408 posts found.

EMA

EMA in push for more paediatric drug trials

July 24, 2015 Medical Communications, Research and Development EMA, European Medicines Agency, clinical trials, drug development, paediatrics

The European Medicines Agency has relaxed some of its rules around the development of drugs in children, in order to …
NHS sign

Cancer Drugs Fund assessment to be handed over to NICE

July 22, 2015 Medical Communications, Research and Development CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, NHSE, NICE, cost effectiveness, cost-effectiveness

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
Janssen image

European Imbruvica approval for Janssen

July 20, 2015 Medical Communications, Sales and Marketing B-cell lymphoma, EC, European Commission, Janssen, Waldenström’s Macroglobulinemia, imbruvica, rare cancer

Janssen has received final European sign-off for its oncology treatment Imbruvica (ibrutinib) as a treatment option for adult patients with …
Chugai

Chugai falls foul of ABPI code for close consultant relationship

July 17, 2015 Medical Communications, Sales and Marketing ABPI Code, Chugai, PMCPA, Prescription Medicines Code of Practice Authority

Bosses at Chugai have been rapped by the industry’s code of practice regulator, after a senior manager failed to declare …
AstraZeneca

AstraZeneca receives US approval for Iressa

July 16, 2015 Medical Communications, Sales and Marketing AstraZeneca, FDA, Iressa, lung cancer, non-small cell lung cancer

AstraZeneca’s lung cancer therapy Iressa has been approved by the FDA – four years after the company pulled it from the …
ABPI

UK pharma made £41 million in doctor payments

July 16, 2015 Medical Communications, Sales and Marketing ABPI, ABPI Code, doctor payments

The pharma industry made £41m in payments to doctors, nurses and other healthcare professionals in the UK in 2014, the …

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015 Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …
Astellas' Ken Jones

Diary of a decade – Ten years in Europe, the Middle East and Africa

July 13, 2015 Medical Communications, Sales and Marketing Astellas, Ken Jones

It’s hard to imagine how much a company can change in a decade.When Astellas Pharma Europe was launched 10 years …
Entyvio

NICE u-turns on Entyvio for Crohn’s disease

July 10, 2015 Medical Communications, Sales and Marketing Crohn's, Crohn’s disease, Entyvio, Millenium, NICE, Takeda, funding

NICE has performed a u-turn and recommended drug treatment Entyvio for Crohn’s disease for routine NHS funding.In final draft guidance …
Daiichi image

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015 Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …
morgan

Pegasus appoints two new members to its pharma team

July 8, 2015 Medical Communications Pegasus

The health communications consultancy Pegasus is expanding its pharma and life sciences division, with the appointment of two new members …
US-EU logo

Pharma ‘paid US doctors $1.5 billion’ in 2014

July 7, 2015 Medical Communications, Sales and Marketing Sunshine Act, US, pharma

Some of the largest European drugmakers paid US doctors and teaching hospitals $1.5 billion in 2014 to participate in promotional …

Adam Zaeske appointed as managing director of Takeda UK and Ireland

July 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adam Zaeske, Takeda

Japanese pharma firm Takeda has appointed Adam Zaeske as managing director of Takeda UK and Ireland.Zaeske has been with Takeda …
Xtandi

Astellas in ‘unacceptable’ Xtandi ABPI code breach

July 3, 2015 Medical Communications, Sales and Marketing ABPI Code, Astella, PMCPA, Xtandi

The industry code of conduct regulator has singled out Astellas for ‘particular censure’ for arranging a meeting for UK healthcare …

Prices to be printed on all prescribed NHS drugs over £20

July 2, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing Jeremy Hunt, NHS, UK, drugs, health secretary, medicines

NHS drugs costing more than £20 will, from next year, have the price and the words “funded by the UK …
The Gateway to Local Adoption Series

Latest content